Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic‐based data
Nearly 70% of clients initiating medication for opioid use disorder (MOUD) at integrated care centers (ICCs) in India stop MOUD use within 1 year, with trajectories characterized by the rate of decline in engagement. Clients with better MOUD adherence appear to return more frequently for HIV testing at the ICCs, underscoring the value of integrated care models.
Authors
- Aylur K. Srikrishnan (ORCID: https://orcid.org/0000-0002-0533-6836)
- Shruti H. Mehta (ORCID: https://orcid.org/0000-0002-2523-0959)
- Allison M. McFall
- Gregory M. Lucas (ORCID: https://orcid.org/0000-0002-3013-4339)
- Sunil S. Solomon (ORCID: https://orcid.org/0000-0002-3296-1514)
- Lakshmi Ganapathi (ORCID: https://orcid.org/0000-0001-5055-0834)
- Conjeevaram K. Vasudevan
- Mihili P Gunaratne
- Santhanam Anand
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Massachusetts General Hospital (US)
- YR Gaitonde Centre for AIDS Research and Education (IN)
Publication Details
- Journal
- Addiction
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1111/add.16713
- Primary Topic
- HIV, Drug Use, Sexual Risk
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johns Hopkins University
- National Institutes of Health
- Center for AIDS Research, University of Washington
- Center for AIDS Research, Johns Hopkins University
- National Institute on Aging
- National Heart, Lung, and Blood Institute
- National Institute on Drug Abuse
- National Cancer Institute
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Minority Health and Health Disparities